Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome

NCT02710084 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Phelan-McDermid Syndrome

Interventions

DRUG: Oxytocin
DRUG: Saline

Sponsor

Alexander Kolevzon